Ceryvyn Therapeutics Limited

Ceryvyn Therapeutics Limited

CKDXF
Ceryvyn Therapeutics LimitedUS flagOther OTC
0.01
USD
- -
- -
13.68MMarket Cap

Ceryvyn Therapeutics Limited (CKDXF) Stock Split History

Learn about Ceryvyn Therapeutics Limited's most recent 53-for-50 basis stock split on November 14, 2023. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about Ceryvyn Therapeutics Limited's most recent stock split

Split Date: 2023-11-14
Split Ratio: 53:50
Price Before Split: $0.31
Price After Split: $0.29

Developer API

Get CKDXF split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/CKDXF

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 1.06 times more shares (a 53:50 ratio)
  • The price per share is reduced proportionally

Historical Stock Splits

A comprehensive history of Ceryvyn Therapeutics Limited's stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2023-11-1453:50No$0.31$0.29

About Ceryvyn Therapeutics Limited

Company overview and industry information

Ceryvyn Therapeutics Limited (CKDXF) operates in the Biotechnology industry. The recent 53-for-50 stock split reflects the company's growth and strategy to make shares more accessible to a broader range of investors.

Biotechnology
Go to Ceryvyn Therapeutics Limited Summary

Last updated: 7/22/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.